HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heiner Wedemeyer Selected Research

Transplantation

1/2021Liver stiffness across different chronic liver disease under therapy with statin in a real life cohort.
10/2020Long-Term Study of Hepatitis Delta Virus Infection at Secondary Care Centers: The Impact of Viremia on Liver-Related Outcomes.
9/2014Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infection.
3/2012Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection.
3/2011Republished paper: Managing HBV in patients with impaired immunity.
10/2010Managing HBV in patients with impaired immunity.
1/2010Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Heiner Wedemeyer Research Topics

Disease

186Infections
04/2024 - 02/2002
69Fibrosis (Cirrhosis)
03/2024 - 11/2004
67Hepatitis C
03/2023 - 07/2004
65Chronic Hepatitis C
04/2024 - 02/2002
38Liver Diseases (Liver Disease)
03/2024 - 01/2007
37Chronic Hepatitis B
02/2024 - 10/2007
34Hepatocellular Carcinoma (Hepatoma)
04/2024 - 12/2004
33Hepatitis B
02/2024 - 01/2003
30Hepatitis D
10/2023 - 03/2009
27Liver Cirrhosis (Hepatic Cirrhosis)
03/2024 - 11/2004
25Hepatitis
12/2023 - 01/2005
22Chronic Hepatitis (Chronic Active Hepatitis)
05/2024 - 01/2010
19Virus Diseases (Viral Diseases)
04/2024 - 02/2002
19Neoplasms (Cancer)
04/2024 - 03/2005
12Disease Progression
05/2024 - 10/2008
12Chronic Hepatitis D
03/2024 - 03/2010
12Ascites
12/2023 - 01/2017
11Coinfection
10/2023 - 03/2007
11Viremia
03/2023 - 01/2008
11Autoimmune Hepatitis
01/2023 - 01/2011
10Inflammation (Inflammations)
01/2023 - 01/2010
9Hemorrhage
05/2024 - 09/2014
9Non-alcoholic Fatty Liver Disease
12/2023 - 12/2016
8Hepatitis E
12/2023 - 01/2011
7Persistent Infection
03/2024 - 02/2006
7End Stage Liver Disease
04/2023 - 03/2008
7Liver Failure
01/2021 - 11/2007
6Portal Hypertension
03/2024 - 11/2015
4Thrombocytopenia (Thrombopenia)
09/2023 - 09/2014
4COVID-19
02/2023 - 12/2020
4Autoimmune Diseases (Autoimmune Disease)
01/2023 - 01/2014
4Reinfection
11/2019 - 10/2006
4Hepatitis A (Hepatitis, Infectious)
11/2018 - 12/2006
4HIV Infections (HIV Infection)
01/2018 - 10/2011
3Carcinogenesis
04/2024 - 06/2012
3Hepatic Encephalopathy
02/2024 - 08/2020
3Thrombosis (Thrombus)
01/2024 - 01/2019
3Brain Diseases (Brain Disorder)
12/2023 - 03/2008
3Alcoholic Fatty Liver
12/2023 - 10/2020
3Wounds and Injuries (Trauma)
12/2022 - 09/2018

Drug/Important Bio-Agent (IBA)

96Antiviral Agents (Antivirals)IBA
04/2024 - 11/2004
65InterferonsIBA
03/2024 - 02/2002
56RNA (Ribonucleic Acid)IBA
07/2023 - 01/2005
52Ribavirin (Virazole)FDA LinkGeneric
03/2024 - 02/2002
40Hepatitis B Surface Antigens (HBsAg)FDA Link
04/2024 - 01/2008
29DNA (Deoxyribonucleic Acid)IBA
02/2024 - 10/2007
24Interferon-alpha (Interferon Alfa)IBA
08/2023 - 02/2002
22AntigensIBA
02/2024 - 10/2007
20VaccinesIBA
01/2023 - 10/2006
17Biomarkers (Surrogate Marker)IBA
01/2024 - 11/2011
17Hepatitis B e AntigensIBA
12/2023 - 01/2008
16AntibodiesIBA
12/2023 - 01/2009
16Proteins (Proteins, Gene)FDA Link
05/2023 - 07/2004
13bulevirtideIBA
05/2024 - 01/2019
13CytokinesIBA
01/2022 - 10/2011
11SofosbuvirIBA
03/2024 - 01/2014
11Peptides (Polypeptides)IBA
10/2019 - 09/2007
10peginterferon alfa-2a (Pegasys)FDA Link
01/2020 - 01/2011
9AlbuminsIBA
07/2023 - 08/2014
9BilirubinIBA
12/2021 - 03/2008
9Protease Inhibitors (Protease Inhibitor)IBA
01/2021 - 04/2005
8Alanine Transaminase (SGPT)IBA
04/2023 - 01/2008
8telaprevirIBA
01/2016 - 01/2013
7Tenofovir (Viread)FDA Link
10/2023 - 01/2010
7glecaprevir and pibrentasvirIBA
01/2022 - 01/2018
7N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
01/2016 - 02/2009
6EnzymesIBA
12/2023 - 09/2014
6Surface Antigens (Surface Antigen)IBA
01/2018 - 01/2008
6entecavirFDA Link
11/2016 - 04/2010
6adefovirIBA
12/2015 - 01/2011
5Transaminases (Aminotransferases)IBA
12/2023 - 09/2018
5Viral RNAIBA
12/2023 - 11/2004
5Immunoglobulin G (IgG)IBA
01/2023 - 01/2010
5EpitopesIBA
01/2022 - 12/2009
5Immunoglobulins (Immunoglobulin)IBA
12/2021 - 10/2006
5dasabuvirIBA
11/2018 - 05/2014
5ombitasvirIBA
11/2018 - 05/2014
5paritaprevirIBA
11/2018 - 05/2014
5Ritonavir (Norvir)FDA Link
11/2018 - 05/2014
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2021 - 01/2020
4NucleosidesIBA
06/2013 - 10/2006
3Glycoproteins (Glycoprotein)IBA
04/2024 - 05/2010
3AutoantibodiesIBA
01/2023 - 01/2022
3Norepinephrine (Noradrenaline)FDA LinkGeneric
12/2022 - 11/2021

Therapy/Procedure

133Therapeutics
09/2023 - 12/2002
40Liver Transplantation
01/2024 - 10/2006
8Duration of Therapy
01/2020 - 10/2006
7Transjugular Intrahepatic Portasystemic Shunt
05/2024 - 01/2018
7Surgical Portasystemic Shunt (Portosystemic Shunt)
11/2023 - 05/2017
7Immunotherapy
01/2023 - 03/2005
7Transplantation
01/2021 - 01/2010
5Contraindications
07/2023 - 05/2017
5Aftercare (After-Treatment)
06/2023 - 12/2015
5Drug Therapy (Chemotherapy)
01/2018 - 10/2010
4Opiate Substitution Treatment
01/2019 - 07/2013
3Renal Dialysis (Hemodialysis)
10/2023 - 01/2003
3Retreatment
08/2023 - 04/2014
3Catheters
07/2023 - 05/2017
3Organ Transplantation
01/2023 - 12/2014
3Plasma Exchange
12/2022 - 11/2021